Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abandonment, aforementioned, attempt, borrower, boundary, Bruce, calendar, canvassing, capacity, cease, consent, contact, coverage, curtail, deposit, detail, Dicema, Director, disability, discretionary, distribution, divert, Dr, employer, employment, endpoint, entice, enticement, estate, exploiting, foregoing, futility, guarantor, harm, insurance, ITEM, iv, Kowalski, landlord, leave, leaving, lender, lessee, lessor, lump, Lutwyche, manner, Mark, merged, Michael, MonsantoThe, path, pending, person, personal, Peter, preceding, predefined, President, procure, reassessed, resignation, restricted, salary, satisfactory, serve, serving, statistical, subcontract, submission, sum, supplier, suspended, tenant, ticker, unclear, underway, unused, vacation, William, withholding
Removed:
cornerstone, identifying, inactive, Inex, outlined, UNREGISTERED
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 3.1 Exhibit 3.1
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 10.9 Exhibit 10.9
- 10.10 Exhibit 10.10
- 10.11 Exhibit 10.11
- 10.12 Exhibit 10.12
- 10.13 Exhibit 10.13
- 10.14 Exhibit 10.14
- 31.1 Exhibit 31.1
- 31.2 Exhibit 31.2
- 32.1 Exhibit 32.1
- 32.2 Exhibit 32.2
- Download Excel data file
- View Excel data file
Related press release
ABUS similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Arbutus Biopharma Corporation, formerly Tekmira Pharmaceuticals Corporation, (the “Company”), for the quarter ended June 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I Mark Murray, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly represents, in all material respects, the financial condition and results of the operations of the Company. |
Date: August 6, 2015
/s/ Mark Murray | ||
Name: | Mark Murray | |
Title: | President and Chief Executive Officer |